Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Photobiomodulation to Alter Cerebral Blood Flow and to Affect the Emotional Status of Patients With Major Depression [Phase 1]
A Phase 1 clinical trial evaluating photobiomodulation to modify cerebral blood flow and emotional status in patients with major depressive …
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating DVS-233 SR for major depressive disorder in adult outpatients has completed. The update does not provide…
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder [Phase 3]
Wyeth, now a Pfizer subsidiary, completed a Phase 3 trial evaluating DVS-233 SR in adults with major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder [NA]
A completed clinical trial evaluated DVS-233 SR for major depressive disorder in elderly outpatients; sponsor Wyeth is now part of Pfizer.
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder [Phase 3]
A Phase 3 study evaluating DVS-233 for adults with Major Depressive Disorder has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating the antidepressant DVS-233 SR in adults with major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-18Clinical Trial Update: Mirtazapine Reduces ICD Shocks in ICD Patients With Depression and Anxiety [NA]
A completed clinical trial evaluated whether mirtazapine reduces ICD shocks in patients with implantable cardioverter-defibrillators who als…
-
FDA approval · 2009-08-07FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
FDA approved a supplemental application from Apotex Corp for Paxil (paroxetine hydrochloride).
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: Chronos: the Use of Chronobiological Treatment in Depression [NA]
Chronos trial studying chronobiological treatment for major depressive disorder has completed. The study was conducted by Hillerod Hospital …
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Ethnic Variations in Antidepressant Response [Phase 4]
A Phase 4 clinical trial update reports on ethnic variations in antidepressant response among individuals with depression.
-
CLINICAL_TRIALS research · 2009-08-03Clinical Trial Update: Getting Biased Treatment Study: How Psychotherapy and Antidepressants Change Brain Activity in Chronic Depression [NA]
This clinical trial update from Charite University describes a study examining how psychotherapy and antidepressants alter brain activity in…
-
CLINICAL_TRIALS trial_result · 2009-07-30Clinical Trial Update: Cytokine-Associated Depression and Social Pain [EARLY_Phase 1]
A Phase 1 trial from UCLA investigating cytokine-related mechanisms of depression and social pain has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Vascular Effects of Sertraline in Heart Failure
This update notes the termination of a Yale University-sponsored trial evaluating the vascular effects of sertraline in patients with heart …
-
FDA approval · 2009-07-22FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc. under ANDA076690, authorizing …
-
CLINICAL_TRIALS trial_result · 2009-07-17Clinical Trial Update: Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder [Phase 3]
A Phase 3 trial compared duloxetine with placebo for preventing recurrence of major depressive disorder. The study completed and results wer…
-
CLINICAL_TRIALS trial_result · 2009-07-17Clinical Trial Update: A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients [Phase 4]
Phase 4 randomized study comparing duloxetine to placebo in adults with major depressive disorder, evaluating energy and vitality; results w…
-
CLINICAL_TRIALS trial_result · 2009-07-15Clinical Trial Update: Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 Months
A multi-country observational study sponsored by Eli Lilly to measure how frequently sexual dysfunction occurs with antidepressants (SSRIs o…
-
CLINICAL_TRIALS trial_result · 2009-07-15Clinical Trial Update: Taboo Perception of Incontinence, Depression and Cancer
This update reports on a completed clinical trial from the Medical University of Vienna exploring taboo perceptions related to urinary incon…
-
CLINICAL_TRIALS trial_result · 2009-07-09Clinical Trial Update: Affective Processing in Depression and Epilepsy
The trial update indicates termination of NCT00855725, a study of affective processing in individuals with epilepsy and major depressive dis…
-
FDA label_change · 2009-07-08FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for trazodone hydrochloride (Teva) resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2009-07-02Clinical Trial Update: Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder [Phase 2]
Phase 2 trial comparing citalopram alone to citalopram plus pindolol in adults with major depressive disorder has completed.
-
FDA approval · 2009-07-01FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approves a supplemental application for Bupropion hydrochloride (ANDA 076143) submitted by BluePoint Laboratories.
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Outcome Following Antidepressant Treatment on Possible Endo-Phenotypes for Major Depression [Phase 4]
Phase 4 clinical trial update evaluating antidepressant treatment and its effects on possible endo-phenotypes in major depressive disorder; …
-
FDA approval · 2009-06-22FDA Approved: CITALOPRAM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for generic citalopram.
-
CLINICAL_TRIALS trial_result · 2009-05-29Clinical Trial Update: Pulsed Electro Magnetic Fields (PEMF) Treatment in Patients With Treatment-Resistant Major Depression in Ongoing Pharmacological Treatment of Depression [Phase 3]
Phase 3 trial evaluating pulsed electromagnetic field therapy for treatment-resistant major depression completed; no efficacy results are pr…